Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A11 | P48066 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.39 |
| ▸ | DRD4 | P21917 | 2/20 | 0.39 |
| ▸ | DRD3 | P35462 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.39 |
| ▸ | PRKDC | P78527 | 2/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18032698 | 0.90 | DPP4 (0.42) | SLC6A11KCNH2HDAC1HDAC2SRD5A1 | |
| SCHEMBL18699207 | 0.86 | CHEK1 (0.35) | SLC6A11KCNH2HDAC1HDAC2PGR | |
| SCHEMBL8980806 | 0.81 | SLC6A11 (0.54) | SLC6A11KCNH2HDAC1HDAC2PGR | |
| SCHEMBL13058814 | 0.80 | CDC25A (0.45) | DRD2DRD4DRD3 | |
| SCHEMBL18699156 | 0.78 | CHEK1 (0.40) | HDAC1HDAC2HDAC3GABRA1GABRG2 | |
| SCHEMBL14854167 | 0.76 | GABRA1 (0.39) | SLC6A11KCNH2HDAC1HDAC2PGR | |
| SCHEMBL18032694 | 0.75 | PGR (0.45) | PGRPRKDC | |
| SCHEMBL12725187 | 0.74 | LTA4H (0.44) | SLC6A11KCNH2HDAC2PGRSRD5A1 | |
| SCHEMBL15571925 | 0.74 | PRF1 (0.53) | SRD5A1DRD2DRD4DRD3 | |
| SCHEMBL18032704 | 0.73 | MAPT (0.37) | PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9917260-B2 | Compounds with terminal heteroarylcyanovinylene groups and their use in organic solar cells | BASF SE (DE) | 2018-03-13 | — | — | US | disclosed |
| EP-2205657-B1 | KETOPYRROLES AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2017-04-05 | — | — | EP | disclosed |
| US-20160248021-A1 | COMPOUNDS WITH TERMINAL HETEROARYLCYANOVINYLENE GROUPS AND THEIR USE IN ORGANIC SOLAR CELLS | BASF SE (DE) | 2016-08-25 | — | — | US | disclosed |
| US-8758880-B2 | Ketopyrroles as organic semiconductors | BASF SE (DE) | 2014-06-24 | — | — | US | disclosed |
| US-8758880-B2 | Ketopyrroles as organic semiconductors | BASF SE (DE) | 2014-06-24 | — | — | US | disclosed |
| US-20100297405-A1 | KETOPYRROLES AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100297405-A1 | KETOPYRROLES AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2010-11-25 | — | — | US | disclosed |
| WO-2009053291-A1 | KETOPYRROLES AS ORGANIC SEMICONDUCTORS | BASF SE (CH) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297405-A1 | KETOPYRROLES AS ORGANIC SEMICONDUCTORS | FOXK1, PDK1, PKN1 | SLC6A11 1719/4885KCNH2 9/4885HDAC1 1035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.